共 17 条
[1]
Resistance to bismuth among gram-negative bacteria is dependent upon iron and its uptake. Domenico P,Reich J,Madonia W,Cunha BA. Journal of Antimicrobial Chemotherapy . 1996
[2]
Competitive binding of the anticancer drug titanocene dichloride to N, N- ethylenebis- (o- hydroxyphenylglycine)and adenosine triphosphate: a model for Ti iv uptake and release by transferrin. Guo M,Sadler PJ. Journal of the Chemical Society Dalton Transactions . 2000
[3]
Antitumour metallocenes: Structure-activity studies and interactions with biomolecules. Harding MM,Mokdsi G. Current Medicinal Chemistry . 2000
[4]
Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. Sun H,Li H,Mason AB,Woodworth RC,Sadler PJ. Journal of Biological Chemistry . 2001
[5]
Binding and transport of nonferrous metals by serum transferrin. Harris WR. Structure and Bonding . 1998
[6]
Comparison of the antiproliferative activity of two antitumor ruthenium (Ⅲ)complexes with their apotransferrin and transferrin-bound forms in human clon cancer cell line. Kratz F,Keppler BK,Hartmann M,Messori L,Berger MR. Metal Based Drugs . 1996
[7]
Formation of titanium(Ⅳ) transferrin by reaction of human serum apotransferrin with titanium complexes. Messori L,Orioli P,Banholzer V,Pais I,Zatta P. FEBS Letters . 1999
[8]
Mechanisms of therapeutic activity for gallium. Bernstein LR. Pharmacology Reviews . 1998
[9]
Cellular effects of transferrin coordinated to[Cl(NH3 ) 5 Ru] Cl2 and cis-[Cl2 (NH3 ) 4 Ru] Cl. Frasca DR,Gehrig LE,Clarke MJ. Journal of Inorganic Biochemistry . 2001
[10]
Non- platinum chermotherapeutic metallopharmaceuticals. Clarke MJ,Zhu F,Frasca DR. Chemical Reviews . 1999